Recent studies into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are demonstrating promising effects in treating excess mass and related 2 disease. Animal data suggest a distinct action contributing to https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/